Floatz Rating
BB69/100
Confidence
Indicative
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Modality
mixture
Development Phase
Phase 4 / Approved
Status
Active
Evidence ledger · v0.2
Clinical Evidence
Clinical track record: trial progression, reported outcomes, safety signals, and endpoint quality.
67High confidence
Detailed axis rationale is planned and will be published soon.
| Trial | Phase | Status | N | Primary endpoint | Readout |
|---|---|---|---|---|---|
NCT06538077CT.gov BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE | — | Recruiting | — | — | — |
NCT06121492CT.gov Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With Sarcopenia | — | Enrolling By Invitation | — | — | — |
NCT06121479CT.gov Oral Branched-chain Amino Acid Supplementation for Decompensated Cirrhotic Patients | — | Enrolling By Invitation | — | — | — |
NCT05724485CT.gov Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis | — | Completed | — | — | — |
NCT03908255CT.gov Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma | — | Withdrawn | — | — | — |
NCT04243148CT.gov Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial Intervention | — | Completed | — | — | — |
NCT03633279CT.gov Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C | — | Active Not Recruiting | — | — | — |
NCT02755701CT.gov The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites | — | Unknown | — | — | — |
Competitive Position
Competitive setting: how crowded the indication is, class-level failures, and timing against rivals.
73High confidence
Detailed axis rationale is planned and will be published soon.
Same indication · Cirrhosis Of Liver
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
| Amino Acids, Branched-Chain (this asset) | Post Graduate Institute of Medical Education and Research, Chandigarh | Approved | BB · 69 |
| Veruprevir | AbbVie | P3 | A |
| Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-Nh2 (4-9 Disulfide) | General Hospital of Shenyang Military Region | P4 | BBB |
| Tolvaptan | Institute of Liver and Biliary Sciences, India | P4 | BBB |
| Ribavirin | Peking University People's Hospital | P4 | BBB |
| Cholyl-Lysl-Fluorescein | Norgine | P3 | BBB |
| Normal Human Serum Albumin | King George's Medical University | P4 | BBB |
| Ombitasvir | AbbVie | P3 | BBB |
| Colchicinum | Beth Israel Deaconess Medical Center | P4 | BBB |
+42 more in the Cirrhosis Of Liver cohort
Other indications for Amino Acids, Branched-Chain
| Indication | Sponsor | Phase | Rating |
|---|---|---|---|
| Hepatic Encephalopathy | — | P4 | B · 62 |
| Traumatic Brain Injury | — | P2 | B · 57 |
| Hepatocellular Carcinoma | — | P2 | CCC · 53 |
Scientific Foundation
Strength of the underlying biology: target validation, tractability, modality fit, and how related mechanisms have fared.
NR
Planned for methodology v0.2.
Development Feasibility
How realistically the program can be executed, drawing on modality precedent, enrollment dynamics, and sponsor delivery.
NR
Planned for methodology v0.2.
Commercial Opportunity
Commercial prize: addressable population, unmet need, and the value case for the indication.
NR
Planned for methodology v0.2.
IP & Exclusivity
Exclusivity position, covering patent protection and freedom-to-operate runway.
NR
Planned for methodology v0.2.
Manufacturing & Supply
Manufacturing and supply readiness, driven by modality process and scale-up risk.
NR
Planned for methodology v0.2.
Related assets
Citation
Floatz Terminal. Amino Acids, Branched-Chain in Cirrhosis Of Liver. Methodology v0.2. Rated under v0.2 effective July 8, 2026. Last refreshed July 8, 2026. Accessed July 14, 2026. https://terminal.floatz.ai/assets/amino-acids-branched-chain-cirrhosis-of-liver
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →